| Literature DB >> 27052022 |
Atif Ali Hashmi1, Zubaida Fida Hussain1, Aneel Roy Bhagwani1, Muhammad Muzzammil Edhi2, Naveen Faridi1, Syed Danish Hussain3, Mehmood Khan4.
Abstract
BACKGROUND: Ovarian cancer is the most lethal gynecologic malignancy and it represents third most common malignancy in Karachi (after breast and oral cancer). Due to lack of well established cancer registry in our country, changing trends of ovarian tumors has not been determined. Therefore we aimed to establish the current trends and classification of ovarian tumors in our setup according to latest WHO guidelines.Entities:
Keywords: Mucinous ovarian tumors; Ovarian tumors; Pakistan
Mesh:
Year: 2016 PMID: 27052022 PMCID: PMC4822320 DOI: 10.1186/s13104-016-2015-5
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Age distribution of ovarian tumors
| Age groups | ||||
|---|---|---|---|---|
| <20 years | 20–40 years | 40–60 years | >60 years | |
| n (%) | n (%) | n (%) | n (%) | |
| Surface epithelial tumor | ||||
| Benign | 14 (17.1) | 44 (53.7) | 18 (22) | 6 (7.3) |
| Borderline | 2 (25.0) | 4 (50) | 2 (25) | 0 (0) |
| Malignant | 0 (0) | 7 (38.9) | 4 (22.2) | 7 (38.9) |
| Germ cell tumor | ||||
| Benign | 3 (8.1) | 27 (73.0) | 5 (13.5) | 2 (5.4) |
| Malignant | 4 (66.7) | 2 (33.3) | 0 (0) | 0 (0) |
| Sex cord stromal tumor | ||||
| Benign | 1 (14.3) | 3 (42.9) | 0 (0) | 3 (42.9) |
| Malignant | 0 (0) | 1 (100.0) | 0 (0) | 0 (0) |
| Metastatic tumor | ||||
| Malignant | 0 (0) | 0 (0) | 1 (100) | 0 (0) |
Tumor size distribution of ovarian neoplasms
| Tumor size | Tumor size category | ||||
|---|---|---|---|---|---|
| Mean | <5 cm | 5–10 cm | 10–20 cm | >20 cm | |
| n (%) | n (%) | n (%) | n (%) | ||
| Surface epithelial tumor | |||||
| Benign | 10.31 | 15 (18.3) | 36 (43.9) | 27 (32.9) | 4 (4.9) |
| Borderline | 19.56 | 0 (0) | 0 (0) | 6 (66.7) | 3 (33.3) |
| Malignant | 19.08 | 1 (5.6) | 3 (16.7) | 6 (33.3) | 8 (44.4) |
| Germ cell tumor | |||||
| Benign | 10.41 | 4 (10.5) | 19 (50) | 13 (34.2) | 2 (5.3) |
| Malignant | 14.15 | 1 (16.7) | 0 (0) | 4 (66.7) | 1 (16.7) |
| Sex cord stromal tumor | |||||
| Benign | 15.07 | 0 (0) | 2 (28.6) | 4 (57.1) | 1 (14.3) |
| Malignant | 23.0 | 0 (0) | 0 (0) | 0 (0) | 1 (100.0) |
| Secondary malignancy | |||||
| Malignant | 6.0 | 0 (0) | 1 (100) | 0 (0) | 0 (0) |
Histopathologic characteristics of borderline and malignant ovarian tumors
| Capsular invasion | Omental metastasis | Pelvic lymph node metastasis | Uterine involvement | Cervical involvement | Contalateral ovarian involvement | Fallopian tube involvement | |
|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Borderline | |||||||
| Serous tumours | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Mucinous tumours | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Malignant | |||||||
| Serous tumours | 2 (50) | 1 (25) | 1 (25) | 1 (25) | 0 (0) | 0 (0) | 1 (25) |
| Mucinous tumours | 1 (14.3) | 2 (28.6) | 1 (14.3) | 1 (14.3) | 1 (14.3) | 0 (0) | 1 (14.3) |
| Endometrioid carcinoma | 3 (75) | 2 (40) | 0 (0) | 1 (20) | 0 (0) | 0 (0) | 3 (60) |
| Transitional cell car | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Dysgerminoma | 1 (50) | 1 (50) | 0 (0) | 1 (50) | 1 (50) | 0 (0) | 0 (0) |
| Yolk sac tumor | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Fibrosarcoma | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |